Publication Date:
2018-03-24
Description:
Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes, Published online: 23 March 2018; doi:10.1038/s41467-018-03631-z Patients’ selection is particularly important in cancer treatment. Here the authors present a proof-of-principle methodology that could be potentially important in assisting therapeutic decisions in the treatment of breast cancer patients.
Electronic ISSN:
2041-1723
Topics:
Biology
,
Chemistry and Pharmacology
,
Natural Sciences in General
,
Physics